J
Jin-Wen Song
Researcher at Chinese PLA General Hospital
Publications - 60
Citations - 10333
Jin-Wen Song is an academic researcher from Chinese PLA General Hospital. The author has contributed to research in topics: Medicine & Immune system. The author has an hindex of 13, co-authored 40 publications receiving 7018 citations. Previous affiliations of Jin-Wen Song include Academy of Military Medical Sciences.
Papers
More filters
Journal ArticleDOI
Systematic Discovery and Pathway Analyses of Metabolic Disturbance in COVID-19
Bowen Li,Xing Fan,Wen-Jing Cao,He Tian,Siyu Wang,Ji-Yuan Zhang,Sin Man Lam,Jin-Wen Song,Chao Zhang,Shaohua Zhang,Zhe Xu,Ruonan Xu,Junliang Fu,Lei Huang,Tian-Jun Jiang,Ming Shi,Fu-Sheng Wang,Guanghou Shui +17 more
Journal ArticleDOI
Gemcitabine-induced heparanase promotes aggressiveness of pancreatic cancer cells via activating EGFR signaling
Jin-Wen Song,Ying-Xia Tan,Su-Bo Li,Zhang Shikun,Lu-Ming Wan,Shou-Ping Ji,Hong Zhou,Zhi-hang Zhou,Feng Gong +8 more
TL;DR: It is demonstrated that gemcitabine-induced HPA1 promotes proliferation and invasion of PC cells through activating EGFR, implying that H PA1 may serve as promising therapeutic target in the treatment of PC.
Journal ArticleDOI
Reduction of natural killer cells is associated with poor outcomes in patients with hepatitis B virus-related acute-on-chronic liver failure
Huajie Li,Ning Yang,Xiuying Mu,Lili Tang,Song-shan Wang,Chun-Bao Zhou,Jin-Hong Yuan,Hai-Yan Wang,Ying-Ying Yu,Jing Li,Siyu Chen,Zhi-Qian Feng,Tao Yang,Kai Liu,Wen-Jing Cao,Ming-Ju Zhou,Chao Zhang,Ji-Yuan Zhang,Yanmei Jiao,Jin-Wen Song,Xing Fan,Min Shi,Ruonan Xu,Fu-Sheng Wang +23 more
TL;DR: NK cells were significantly decreased and showed dysfunction of phenotypic and functional profiles across distinct subsets in the peripheral blood of patients with ACLF, and understanding the dysfunction and decrease in NK cells may provide new insights into ACLF pathogenesis.
Posted ContentDOI
Treatment with human umbilical cord-derived mesenchymal stem cells for COVID-19 patients with lung damage: a randomised, double-blind, placebo controlled phase 2 trial
Lei Shi,Hai Huang,Xuechun Lu,Xiaoyan Yan,Xiaojing Jiang,Ruonan Xu,Siyu Wang,Chao Zhang,Xin Yuan,Zhe Xu,Lei Huang,Junliang Fu,Yuanyuan Li,Yu Zhang,Wei-Qi Yao,Tianyi Liu,Jin-Wen Song,Liangliang Sun,Fan Yang,Xin Zhang,Bo Zhang,Ming Shi,Fanping Meng,Yanning Song,Yongpei Yu,Jiqiu Wen,Qi Li,Qing Mao,Markus Maeurer,Alimuddin Zumla,Chen Yao,Wei-Fen Xie,Fu-Sheng Wang +32 more
TL;DR: The trial suggests that UC-MSCs administration might benefit patients with COVID-19 with lung damage at the convalescent stage as well as the progression stage, with a trend of numerical improvement in whole lung lesions from baseline to day 28 compared with the placebo cases.
Journal ArticleDOI
CCL5-Secreting Virtual Memory CD8+ T Cells Inversely Associate With Viral Reservoir Size in HIV‐1−Infected Individuals on Antiretroviral Therapy
Wei Hu,Yan-jun Li,Cheng Zhen,You Wang,Hui-Huang Huang,Jun Zou,Yan-Qing Zheng,G C Huang,Siyan Meng,Jie-Hua Jin,Jing Li,Ming-Ju Zhou,Yuejun Fu,Peng Zhang,Xiaoyan Li,Tao Yang,Xiu-Wen Wang,Xiugao Yang,Jin-Wen Song,Xing Fan,Yanmei Jiao,Ruonan Xu,Ji-Yuan Zhang,Chun-Bao Zhou,Jin-Hong Yuan,Lei Huang,Ya-Qin Qin,F. Wu,Min Shi,Fu-Sheng Wang,Chao Zhang +30 more
TL;DR: This study highlights CCL5-secreting TVM cells subset as a potential determinant of HIV-1 reservoir size to design CD8+ T cell-based therapeutic strategies for cure of the disease.